References
- Lipsky PE , van der Heijde DM, St Clair EW et al. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study group. N. Engl. J. Med.343 , 1594–1602 (2000).
- Strand V , KimberlyR, IsaacsJD. Biologic therapies in rheumatology: lessons learned, future directions. Nat. Rev. Drug Discov.6 , 75–92 (2007).
- Marsal S , JuliaA. Rheumatoid arthritis pharmacogenomics. Pharmacogenomics11 , 617–619 (2010).
- Liu C , BatliwallaF, LiW et al. Genome-wide association scan identifies candidate polymorphisms associated with differential response to anti-TNF treatment in rheumatoid arthritis. Mol. Med. 14 , 575–581 (2008).
- Suarez-Gestal M , Perez-PampinE, CalazaM, Gomez-ReinoJJ, GonzalezA. Lack of replication of genetic predictors for the rheumatoid arthritis response to anti-TNF treatments: a prospective case-only study. Arthritis Res. Ther.12 , R72 (2010).
- Krintel SB , PalermoG, JohansenJS et al. Investigation of single nucleotide polymorphisms and biological pathways associated with response to TNFα inhibitors in patients with rheumatoid arthritis. Pharmacogenet. Genomics 22 , 577–589 (2012).
- Plant D , BowesJ, PotterC et al. Genome-wide association study of genetic predictors of anti-tumor necrosis factor treatment efficacy in rheumatoid arthritis identifies associations with polymorphisms at seven loci. Arthritis Rheum. 63 , 645–653 (2011).
- Arnett FC , EdworthySM, BlochDA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31 , 315–324 (1988).
- van Gestel AM , HaagsmaCJ, van Riel PL. Validation of rheumatoid arthritis improvement criteria that include simplified joint counts. Arthritis Rheum.41 , 1845–1850 (1998).
- So HC , GuiAH, ChernySS, ShamPC. Evaluating the heritability explained by known susceptibility variants: a survey of ten complex diseases. Genet. Epidemiol.35 , 310–317 (2011).
- Obaidat A , RothM, HagenbuchB. The expression and function of organic anion transporting polypeptides in normal tissues and in cancer. Annu. Rev. Pharmacol. Toxicol.52 , 135–151 (2012).
- Hagenbuch B , GuiC. Xenobiotic transporters of the human organic anion transporting polypeptides (OATP) family. Xenobiotica38 , 778–801 (2008).
- Essayan DM . Cyclic nucleotide phosphodiesterases. J. Allergy Clin. Immunol.108 , 671–680 (2001).
- Shenoy P , AgarwalV. Phosphodiesterase inhibitors in the management of autoimmune disease. Autoimmun. Rev.9 , 511–515 (2010).
- Prabhakar U , LipshutzD, BartusJO et al. Characterization of cAMP-dependent inhibition of LPS-induced TNF α production by rolipram, a specific phosphodiesterase IV (PDE IV) inhibitor. Int. J. Immunopharmacol. 16 , 805–816 (1994).
- Co MS , QueenC. Humanized antibodies for therapy. Nature351 , 501–502 (1991).
- Furst DE , WallisR, BroderM, BeenhouwerDO. Tumor necrosis factor antagonists: different kinetics and/or mechanisms of action may explain differences in the risk for developing granulomatous infection. Semin. Arthritis Rheum.36 , 159–167 (2006).
- Morton NE , CollinsA. Tests and estimates of allelic association in complex inheritance. Proc. Natl Acad. Sci. USA95 , 11389–11393 (1998).
- Plenge RM , BridgesSL Jr. Personalized medicine in rheumatoid arthritis: miles to go before we sleep. Arthritis Rheum.63 , 590–593 (2011).
▪ Websites
- The Comprehensive R Archive Network. http://cran.r-project.org
- Gene × Environment, Gene × Gene Interaction (Quanto). http://hydra.usc.edu/gxe
- Genetic Power Calculator. http://pngu.mgh.harvard.edu/~purcell/gpc
- Metal – Meta Analysis Helper. www.sph.umich.edu/csg/abecasis/metal/index.html